Figure 7.
Figure 7. Results of whole-mount in situ hybridization of c-mpl and c-mpl and scl morpholino injection. Shown are the results of whole-mount in situ hybridization with antisense c-mpl cRNA (A; high power, B) at the embryo 3 dpf. c-mpl+ cells are detected in the same location as CD41+ and GFP+ cells detected in previous studies. Injection of a zebrafish c-mpl antisense morpholino (MOc) reduced the number of GFP+ cells 3 and 5 dpf. c-mpl morphants have some residual GFP+ cells. Injection of an inverted morpholino (MOinv) did not decrease the number of circulating GFP+ cells. Injection of 2 scl morpholinos (MOs) also reduced the number of GFP+ cells in the morphants at 4 dpf, in addition to causing tail deformation. For comparison, uninjected siblings of the same developmental stages are posted in the right corner of each picture.

Results of whole-mount in situ hybridization of c-mpl and c-mpl and scl morpholino injection. Shown are the results of whole-mount in situ hybridization with antisense c-mpl cRNA (A; high power, B) at the embryo 3 dpf. c-mpl+ cells are detected in the same location as CD41+ and GFP+ cells detected in previous studies. Injection of a zebrafish c-mpl antisense morpholino (MOc) reduced the number of GFP+ cells 3 and 5 dpf. c-mpl morphants have some residual GFP+ cells. Injection of an inverted morpholino (MOinv) did not decrease the number of circulating GFP+ cells. Injection of 2 scl morpholinos (MOs) also reduced the number of GFP+ cells in the morphants at 4 dpf, in addition to causing tail deformation. For comparison, uninjected siblings of the same developmental stages are posted in the right corner of each picture.

Close Modal

or Create an Account

Close Modal
Close Modal